This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Morgan Stanley Remains a Hold on Icl (ICL)
In a report released yesterday, Lisa De Neve from Morgan Stanley maintained a Hold rating on Icl, with a price target of $5.40. The company’s shares closed yesterday at $5.24.
End of Quarter Sale - 50% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, De Neve is a 3-star analyst with an average return of 2.5% and a 49.21% success rate.
Icl has an analyst consensus of Hold, with a price target consensus of $5.80.
Based on Icl’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.7 billion and a GAAP net loss of $73 million. In comparison, last year the company earned a revenue of $1.6 billion and had a net profit of $70 million
Read More on ICL:
Disclaimer & DisclosureReport an Issue
- ICL opens new specialty fertilizer production facility in India
- ICL Group Updates Investors With New Company Overview and Risk Disclosure
- ICL Group Names SolarEdge Executive Asaf Alperovitz as New CFO Amid Planned Retirement
- ICL names Asaf Alperovitz as new CFO
- ICL Details March 2026 $60 Million Dividend Terms and Tax Treatment
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
